4.6 Article

Doxorubicin Dose-Dependent Impact on Physiological Balance-A Holistic Approach in a Rat Model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Role of oxidative stress and inflammation-related signaling pathways in doxorubicin-induced cardiomyopathy

Saixian Shi et al.

Summary: Doxorubicin is a powerful chemotherapeutic drug used in cancer treatment, but it can cause serious cardiac side effects. Researchers are exploring the molecular mechanisms of doxorubicin-induced cardiomyopathy, focusing on oxidative stress and inflammation.

CELL COMMUNICATION AND SIGNALING (2023)

Article Cell Biology

Intermittent Lead Exposure Induces Behavioral and Cardiovascular Alterations Associated with Neuroinflammation

Liana Shvachiy et al.

Summary: Intermittent lead exposure can induce reactive astrogliosis and microgliosis in the hippocampus of rats, leading to changes in behavioral and cardiovascular function.
Article Chemistry, Medicinal

Exposure to Doxorubicin Modulates the Cardiac Response to Isoproterenol in Male and Female Mice

Kevin Agostinucci et al.

Summary: Sex is an important risk factor in the development of doxorubicin-induced cardiotoxicity. The study found sexual differences in the heart's response to hypertrophic stimuli in doxorubicin-exposed mice. Pre-exposure to doxorubicin caused male-specific cardiac atrophy that persisted after isoproterenol treatment, which could not be prevented by gonadectomy. However, there were no sex differences in the expression of markers of pathological hypertrophy, fibrosis, or inflammation.

PHARMACEUTICALS (2023)

Review Medicine, General & Internal

Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage

Ahmad Syukri et al.

Summary: This review article comprehensively examines the role of HMGB1, HIF-1 alpha, and VEGF in DOX-induced cardiovascular disease and its molecular mechanisms. The findings suggest that HMGB1 serves as a mediator of DOX-induced myocardial damage, while DOX inhibits HIF-1 alpha activity and affects the upregulation of various angiogenic factors, including VEGF. VEGF plays a crucial role in both angiogenesis and anti-angiogenesis, while reducing the side effects of DOX.

ANNALS OF MEDICINE AND SURGERY (2022)

Article Biochemistry & Molecular Biology

Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons

Nicola Moro et al.

Summary: Doxorubicin is commonly used for cancer treatment, but its clinical use is limited by cardiotoxicity. Although the adverse cardiac effects of Doxorubicin are known, the underlying mechanisms are still not fully understood. Recent studies have found that Doxorubicin may not only affect cardiomyocytes but also cardiac sympathetic neurons, which are additional targets of Doxorubicin cardiotoxicity. These findings reveal a previously unrecognized effect of Doxorubicin on cardiac autonomic regulation, which plays a role in cardiac physiology and pathology, including heart failure and arrhythmias.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Cardiac & Cardiovascular Systems

Cardiovascular Dysautonomia in Patients with Breast Cancer

Vera Geraldes et al.

Summary: Breast cancer is the most common malignant disease in women, and survivors are at increased risk of developing other chronic conditions, including cardiovascular diseases. Autonomic dysfunction may serve as an early biomarker of cardiovascular impairment in breast cancer patients. Further research is needed to determine the relevance of autonomic dysfunction and develop interventions to prevent cardiovascular disease.

OPEN CARDIOVASCULAR MEDICINE JOURNAL (2022)

Article Physiology

Cardiac fibrosis in oncologic therapies

Rene R. Sevag Packard

Summary: Cardiotoxicity, a potential side-effect of oncologic therapies, can lead to the development of cardiac fibrosis, which increases the risk of cardiac dysfunction and cardiovascular mortality. This review focuses on the mechanisms of fibroblast activation, myofibroblast transdifferentiation, and the development of cardiac fibrosis as a consequence of cancer treatments. It also discusses clinical strategies for assessing cardiac fibrosis and emerging therapies to prevent or treat fibrosis.

CURRENT OPINION IN PHYSIOLOGY (2022)

Article Biochemistry & Molecular Biology

Doxorubicin Impairs Smooth Muscle Cell Contraction: Novel Insights in Vascular Toxicity

Matthias Bosman et al.

Summary: Chemotherapeutic doxorubicin has been shown to increase arterial stiffness, possibly by reducing vascular smooth muscle cell contraction and Ca2+ influx through Ca2+ channels. However, the specific mechanism remains unclear and requires further investigation. Interestingly, doxorubicin decreased ex vivo arterial stiffness but had minimal effects in vivo, emphasizing the importance of timing in evaluating arterial stiffness in doxorubicin-treated patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Physiology

CAROTID BODY CHEMORECEPTORS: PHYSIOLOGY, PATHOLOGY, AND IMPLICATIONS FOR HEALTH AND DISEASE

Rodrigo Iturriaga et al.

Summary: This review discusses the role of the carotid body in maintaining homeostasis through reflex ventilatory, cardiovascular, and humoral responses. It also examines the transduction mechanisms, synaptic mechanisms, and integrated reflex responses to CB activation in different physiological, pathological, or environmental challenges. The contribution of enhanced CB chemosensory discharge to autonomic and cardiorespiratory pathophysiology in various diseases is also highlighted.

PHYSIOLOGICAL REVIEWS (2021)

Review Oncology

Doxorubicin-Induced Cognitive Impairment: The Mechanistic Insights

Jiajia Du et al.

Summary: Chemotherapy can prolong survival in breast cancer patients, but drugs like doxorubicin may cause cognitive deficits including learning, reasoning, attention, and memory impairments. The mechanisms behind this chemo-brain phenomenon are complex and interconnected, involving DNA damage, oxidative stress, inflammation, apoptosis dysregulation, neurotransmitter changes, mitochondrial dysfunction, glial cell interactions, neurogenesis inhibition, and epigenetic factors.

FRONTIERS IN ONCOLOGY (2021)

Review Pharmacology & Pharmacy

Analysis of Models of Doxorubicin-Induced Cardiomyopathy in Rats and Mice. A Modern View From the Perspective of the Pathophysiologist and the Clinician

Ekaterina Yu Podyacheva et al.

Summary: Currently, there is an expansion in the pharmacological possibilities of treating cancer, leading to an increase in life expectancy with chemotherapy and supportive treatment. However, complications such as anthracycline-induced cardiomyopathy are a significant concern, requiring further research to understand its development mechanisms through new models.

FRONTIERS IN PHARMACOLOGY (2021)

Review Medicine, General & Internal

Inter-Individual Variation and Cardioprotection in Anthracycline-Induced Heart Failure

Nadine Norton et al.

Summary: Anthracyclines, widely used in oncology, have a significant side effect of cardiotoxicity, but progress is being made in predicting high-risk individuals and developing individualized cardioprotective plans through methodology and pharmacogenetic studies.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Pharmacology & Pharmacy

Time course of cardiomyopathy induced by doxorubicin in rats

Daniel J. M. Medeiros-Lima et al.

PHARMACOLOGICAL REPORTS (2019)

Article Pharmacology & Pharmacy

Cardiovascular variability and β-ARs gene expression at two stages of doxorubicin - Induced cardiomyopathy

Marko Vasic et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Article Cardiac & Cardiovascular Systems

Possible Ameliorative Effect of Ivabradine on the Autonomic and Left Ventricular Dysfunction Induced by Doxorubicin in Male Rats

Amany E. El-Naggar et al.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2018)

Review Pharmacology & Pharmacy

Doxorubicin targets multiple players: A new view of an old problem

Donato Cappetta et al.

PHARMACOLOGICAL RESEARCH (2018)

Review Cardiac & Cardiovascular Systems

Oxidative Stress and Cardiac Remodeling: An Updated Edge

Abeer M. Rababa'h et al.

CURRENT CARDIOLOGY REVIEWS (2018)

Review Cardiac & Cardiovascular Systems

Insights into the background of autonomic medicine

Sergio Laranjo et al.

REVISTA PORTUGUESA DE CARDIOLOGIA (2017)

Review Cardiac & Cardiovascular Systems

Cardio-Oncology An Update on Cardiotoxicity of Cancer-Related Treatment

Carrie G. Lenneman et al.

CIRCULATION RESEARCH (2016)

Review Endocrinology & Metabolism

Wnt signaling pathway in cardiac fibrosis: New insights and directions

Hui Tao et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2016)

Article Clinical Neurology

Prognostic Value of Heart Rate Variability in Patients With Cancer

Ying Guo et al.

JOURNAL OF CLINICAL NEUROPHYSIOLOGY (2015)

Article Biophysics

Heart rate dynamics in doxorubicin-induced cardiomyopathy

T. Loncar-Turukalo et al.

PHYSIOLOGICAL MEASUREMENT (2015)

Article Biotechnology & Applied Microbiology

Osthole Attenuates Doxorubicin-Induced Apoptosis in PC12 Cells through Inhibition of Mitochondrial Dysfunction and ROS Production

Yalda Shokoohinia et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Review Cardiac & Cardiovascular Systems

Heart Rate Variability in Risk Stratification of Cardiac Patients

Heikki V. Huikuri et al.

PROGRESS IN CARDIOVASCULAR DISEASES (2013)

Review Cardiac & Cardiovascular Systems

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Yanti Octavia et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)

Article Biochemistry & Molecular Biology

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

Sui Zhang et al.

NATURE MEDICINE (2012)

Review Biochemical Research Methods

Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies

David Montaigne et al.

BIOCHEMISTRY RESEARCH INTERNATIONAL (2012)

Article Oncology

Rapid quantification of myocardial fibrosis: A new macro-based automated analysis

Awal M. Hadi et al.

ANALYTICAL CELLULAR PATHOLOGY (2010)

Review Pharmacology & Pharmacy

Sex Differences in Pharmacokinetics and Pharmacodynamics

Offie P. Soldin et al.

CLINICAL PHARMACOKINETICS (2009)

Article Chemistry, Medicinal

Cardiotoxicity of antitumor drugs

Pierantonio Menna et al.

CHEMICAL RESEARCH IN TOXICOLOGY (2008)

Review Medicine, Research & Experimental

Pathobiology of transforming growth factor β in cancer, fibrosis and immunologic disease, and therapeutic considerations

Gerald J. Prud'homme

LABORATORY INVESTIGATION (2007)

Article Neurosciences

Peripheral chemoreflex and baroreflex interactions in cardiovascular regulation in humans

JR Halliwill et al.

JOURNAL OF PHYSIOLOGY-LONDON (2003)

Article Oncology

Autonomic nervous system dysfunction in advanced cancer

D Walsh et al.

SUPPORTIVE CARE IN CANCER (2002)

Article Cell Biology

Doxorubicin-induced apoptosis: Implications in cardiotoxicity

B Kalyanaraman et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)